Perceptive Advisors’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Perceptive Advisors’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-900,548	Closed	-$230K	–	112
2023 Q1	$230K	Hold	900,548	–	–	0.01%	95
2022 Q4	$1.06M	Hold	900,548	–	–	0.03%	91
2022 Q3	$1.84M	Hold	900,548	–	–	0.05%	103
2022 Q2	$1.39M	Sell	900,548 -25,684	-3%	-$100K	0.04%	99
2022 Q1	$4.68M	Hold	926,232	–	–	0.09%	107
2021 Q4	$5.74M	Buy	+926,232	New	+$8.27M	0.09%	113

Perceptive Advisors's PEAR Position: Q2 2023 in Review

Perceptive Advisors sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 900,548 shares — an estimated $230K sold.

Perceptive Advisors first reported a position in PEAR in Q4 2021 and held it in 6 quarters. The position peaked at $5.74M in Q4 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Perceptive Advisors reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Perceptive Advisors sold 900,548 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $230K.
Perceptive Advisors first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Perceptive Advisors's Pear Therapeutics, Inc. Class A Common Stock position peaked at $5.74M in Q4 2021.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Perceptive Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.